Paydirt
RA
Insider

Raymond Anderson

Director

Raymond Anderson (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales, 1 filed past the two-business-day deadline), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $204K of MNPR (1,802 sh × $113.05, as filed), executed Aug 25.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells · 1 late
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$407K
shares × price, as filed
Last traded
Aug 25
Filed Aug 28

Median ADV $24.7M across their filed names

Open performance
Volume by month
$407K$204K$0Oct 2024Apr 2025Oct 2025Apr 2026Aug 2026 · sells $407K
Buys $0 Sells $407K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names
MNPR Monopar Therapeutics Inc. MNPR · 0 buys · 2 sells 2 filings
Recent filings
MNPRSALE Monopar Therapeutics Inc. View filing → $204K
1,802 sh × $113.05
Exec Aug 25
Filed Aug 28 · 7:41 PM ET †
MNPRSALE Monopar Therapeutics Inc. View filing → $204K
1,802 sh × $113.05
Exec Aug 25
Filed Aug 27 · 6:27 PM ET